CannabisNewsBreaks – GRN Holding Corporation (GRNF), One World Legends Enter Strategic Joint Venture

GRN Holding Corporation (OTC: GRNF) and Marijuana Inc., having recently merged into a consolidated entity, today announced a joint venture with One World Legends (“OWL”), a distinguished player in the cannabis sector. The partnership marks a significant step forward in shaping the future of the cannabis industry and fostering innovation, growth and global collaboration. “We have been working with One World Legends for two years on this project. The joint venture signifies a powerful fusion of expertise, vision and dedication,” said Donald Steinberg, CEO of Marijuana Inc. “OWL has a selection of 17 Landrace strains, which include some famous old strains such as Acapulco Gold, Maui Wowie, Colombian Punta Roja, Durban poison, Jamaican Lambs Breath, Thailand and more. OWL is also growing another selection of 20 more of the most famous hybrid strains in the world, which are currently growing in Colombia in preparation for global distribution… Mr. Petrullo has a ‘one-of-a-kind’ business plan, now being implemented and setting the groundwork for large-scale cannabis distribution, both CBD and THC flower varieties.”

To view the full press release, visit https://cnw.fm/eSOw2

About GRN Holding Corporation

GRN Holding Corporation is a publicly quoted company that recently merged into a consolidated entity with Marijuana Inc. GRN Holding Corporation is currently working on the name change to Marijuana Inc. and the ticker change. The company is involved in the global distribution and sale of marijuana in states and countries where legal to do so. The company has set into motion collaborations with marijuana farmers to distribute high grade, low-cost marijuana to legal consumers, wholesalers and retailers.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — CNN’s Dr. Gupta Discusses Marijuana Use by Seniors

In a recent article titled “Cannabis is Having a Senior Moment,” CNN’s Dr. Sanjay Gupta talked about the increasing rates of marijuana use among older Americans. People aged 65 and older are now the fastest growing group of marijuana users in the country, Gupta said, dubbing the trend a kind of “senior moment” that has left him quite surprised.

America is currently home to a massive state-level medical marijuana industry that serves millions of patients and generates hundreds of millions of dollars per year in medical cannabis sales. Surprisingly, a significant portion of medical marijuana patients are older individuals, belying the idea that cannabis in all its forms is a young man’s game.

Unlike younger, more liberal generations who grew up after the war on drugs, seniors spent their formative years in a world that criminalized cannabis as harshly as cocaine and heroin. They experienced anticannabis sentiment for the majority of their lives and were inundated with messages about the personal and societal ails associated with consuming cannabis.

This generation is now adopting cannabis in surprising numbers, Gupta said, with recent studies indicating that more seniors are using cannabis to address age-related issues such as pain from arthritis and poor sleep. In many cases, seniors prefer to use cannabis in place of prescription opioids, antidepressants and sleeping pills, Gupta noted.

The growing trend of cannabis use among America’s senior population encouraged Gupta to begin working on his most recent documentary, “Weed 7: A Senior Moment.” Gupta notes that cannabis could have “tremendous implications” if it could replace the pharmaceuticals many American seniors take on an almost-daily basis. Prescription pharmaceuticals have a myriad of side effects that can significantly diminish the quality of life of seniors while cannabis doesn’t seem to exhibit severe side effects.

Incorporating cannabis into treatments for seniors could also result in major cost savings as the United States spends close to $600 billion of its annual healthcare budget on pharmaceuticals alone.

With Gupta estimating that more than 30% of seniors take at least five pharmaceuticals per day, overall prescription pharmaceutical medication use may decrease if seniors transition to using cannabis as an alternative medication in mass.

Close to 40 states currently allow their residents to use medical marijuana to address more than 20 medical conditions. These conditions include chronic pain, inflammatory bowel disease, irritable bowel syndrome, obsessive-compulsive disorder and PTSD, to name a few.

This medical use of marijuana lends credence to the efforts by companies such as IGC Pharma Inc. (NYSE American: IGC) to develop FDA-approved formulations from cannabis targeting different disease conditions, such as chronic pain.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW— Maine Enacts Law Granting Cannabis Businesses Tax Relief

Maine Governor Janet Mills has approved legislation to provide tax relief to players in the state’s marijuana industry. The bill will partially bypass the Internal Revenue Service, which prohibits cannabis businesses from making federal tax deductions through IRS code 280E, and grant licensed cannabis businesses access to state tax deductions.

The law expands on previous legislation that already provided licensed medical cannabis operators with tax relief and will allow players in the industry to make tax deductions for business expenses associated with running a manufacturing facility or registered dispensary, or carrying out trade as a registered caregiver.

A statement from the Maine Office of Cannabis Policy (OCP) noted that the legislation would allow licensed cannabis operators to make business expense deductions on their tax returns such as the medical cannabis industry and other conventional sectors.

Marijuana operators in the state will undoubtedly be pleased with the news as cannabis businesses in most states have consistently complained about their large tax burden. Cannabis-related taxes and fees in America’s state-legal cannabis industry are so high that a significant portion of consumers are turning to the illicit market where products are significantly cheaper.

Introduced by Senator Teresa Pierce, the cannabis tax bill would give businesses in the sector the chance to recoup some of the costs through state tax deductions, potentially allowing them to pass on some of their savings to their customers and reduce product prices. According to the bill, the state of Maine would recover the funds it will use for the tax deductions by taking part of the tax revenue earned from medical cannabis sales.

Pierce explains that while businesses that can write off their business costs have an average tax rate of 40% of gross income, businesses without access to tax deductions often pay up to 70% of their gross income as tax. She called the difference in tax code unfair and appalling while testifying before a joint committee and said that it forced business owners to experience losses in order to hire and maintain their workers, offer benefits and reinvest in the business.

This makes it extremely difficult for small operators with limited access to capital to operate in the industry and encourages the development of monopolies by large, multistate companies. Given that Maine’s medical cannabis industry already had access to these tax deductions, Pierce said that it was only fair to extend access to the recreational cannabis industry as well.

This tax relief can allow companies to scale their operations, such as by acquiring more cultivation equipment from manufacturers such as Advanced Container Technologies Inc. (OTC: ACTX), in order to serve more customers.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW— Study Finds Workplace Accident Rates No Different Between Off-Duty Marijuana Users and Non-Users

Employees who engage in off-duty marijuana consumption do not display a higher likelihood of encountering workplace injuries when compared to abstainers, according to recent research that challenges the sweeping zero-tolerance policies commonly adopted by employers. On the other hand, individuals who use marijuana during work hours exhibit a nearly twofold increase in the probability of being involved in a workplace incident, in contrast to both nonusers and those who consume marijuana during their personal time.

This discovery stems from a collaborative effort by researchers hailing from the Toronto Rehabilitation Institute, the University at Buffalo and the University of Toronto. The findings were recently published in the “Canadian Journal of Public Health.”

In two years, the study tracked 2,746 Canadian workers who occupied positions spanning both safety- and nonsafety-sensitive roles. The exhaustive analysis paid specific attention to the 11.3% subset of the sample who sustained workplace injuries during the specified timeframe.

Among the diverse pool of respondents, the investigation highlighted that 10.2% of those affected by workplace injuries were classified as nonusers, with 11.14% identified as off-duty consumers. Meanwhile, a notable 20.13% reported marijuana consumption either within two hours before or during their working hours.

According to study findings, individuals who admitted to using marijuana within the confines of their workplace exhibited a 1.97 times greater risk of encountering workplace injuries in comparison to those who refrained from such consumption. Conversely, no significant association was observed between nonworkplace usage and the occurrence of workplace injuries.

Consequently, the researchers deduced that the critical factor influencing workplace injuries is the proximity of marijuana use to work hours rather than consumption outside of professional settings.

Stratifying the data for safety-sensitive workers revealed that injury rates stood at 20.14% for nonusers, 23.3% for off-duty consumers, and 31.35% for on-the-job indulgers. For nonsafety-sensitive roles, the figures were notably lower, with nonusers experiencing injury at a rate of 4.27%, off-duty users at 4.19%, and those consuming marijuana during work at a higher 12.3%.

The researchers affirmed that their study provides a more lucid perspective on the connection between marijuana use and workplace injuries, an area that previous conflicting studies have clouded. They explained that prior research had neglected the temporal aspect of consumption concerning workplace injuries, which their study effectively accounted for.

Ultimately, the researchers concluded that solely workplace-related marijuana use poses a genuine risk of future workplace injuries, regardless of whether the job role falls within the safety-sensitive category.

Some of the concerns about marijuana use will likely disappear as more enterprises bring to market cannabis-based formulations along the lines of what IGC Pharma Inc. (NYSE American: IGC) is developing for chronic pain management. These medications will move many medical marijuana users away from taking unprocessed cannabis, which is a source of concern for employers and some authorities.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Minnesota Marijuana Drinks Makers Enjoying Great Market Conditions

The cannabis-infused beverages segment of America’s state-legal cannabis market seems to be performing admirably in one of the most unexpected states: Minnesota.

Favorable market conditions in the state have helped cannabis-beverage producers and retailers in the state earn millions of dollars in recent months, making Minnesota one of the best markets for marijuana drinks in not only the United States and Canada but Europe as well.

With recreational cannabis sales slated to begin in less than a year in the state, the recent success of the cannabis-infused drinks segment could be an indication that demand for cannabis and cannabis products among Minnesotans is quite high. Thanks to factors such as easy access, less cannabis-associated stigma and Minnesota’s location, cannabis-infused beverage retailers have been selling an average of more than $1 million worth of products every month.

State regulators allow Minnesotans to purchase cannabis drinks at grocery chains. restaurants, and liquor stores, meaning a significant percentage of Minnesota residents have easy access to cannabis drinks. Furthermore, with the closest states that allow recreational cannabis sales (Michigan and Illinois) being hours away, most residents and consumers from neighboring states have nowhere but Minnesota to purchase low-THC beverages.

Minnesota’s low-THC product segment was born when federal lawmakers passed the 2018 Farm Bill, legalizing the cultivation and sale of industrial hemp (cannabis with less than 0.3% THC) and its derivatives. Since Minnesota doesn’t require that retailers have a license to sell products infused with hemp-derived THC, the segment kicked into overdrive as soon as the Farm Bill became law close to five years ago.

According to Blunt Strategies partner and principal Leili Fatehi, the measure allowed millions of Minnesotans to purchase low-THC offerings as easily as they could buy alcohol.

Furthermore, Fatehi explains, consumers seem to be interested in engaging and learning more about marijuana-infused drinks and how to consume them safely.

Local manufacturers such as Surly Brewing Co. in Minneapolis and interstate players such as California-based Cann have been major winners in the recent cannabis-infused beverage sales boom.

The segment largely owes its success to a 2022 measure that legalized the sale of hemp-derived THC edibles in retail outlets, including convenience and grocery stores that are typically prohibited from taking part in the cannabis market in other states. While some pundits say the explosion in sales is indicative of the market’s demand for recreational cannabis, others believe that changes in adult-use cannabis policy in Minnesota could impact sales.

Minneapolis-based marijuana attorney Jason Tarasek says that recreational cannabis legalization could lead to increased licensing requirements and regulation for players in the hemp-derived THC segment.

On a plus side, the launch of recreational cannabis sales will also bring welcome business opportunities to nationwide ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) as well as lead to the mushrooming of many marijuana enterprises.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Indoor MJ Growers Give Insights into How Preharvest Care Can Optimize Yields

The harvest phase is an essential step in making marijuana products such as flowers and oils. Before the crops are collected, a lot of careful planning and preparation happens. Different growers, whether they’re growing indoors, in greenhouses, or outdoors, need to learn different ways to do this. Each place has its own challenges.

For indoor growing, it’s important to have a clear plan and to be able to watch over the plants closely. Nic Robertson from 4Front Ventures says the company creates daily schedules for its plants leading up to harvest. This is when the plants finish their life cycle. Ryan Cook from Jushi Holdings agrees that planning and preparing well are keys to success in harvesting.

Although there are many ways to grow, there are some things that all successful growers do. They make sure the lighting is right, control the temperature and humidity, manage nutrients and take care of the leaves.

Indoor growers use special lights to help the plants grow. They start with lower-intensity light and gradually increase lighting as the plants develop. This helps the plants make more of the good stuff such as cannabinoids and terpenes, which make the plants valuable. They also use red light to improve the flavors and yields.

Temperature and humidity are important factors too. Growers adjust these to make sure the plants stay healthy and produce good yields. As plants get closer to harvest, the temperature and humidity are lowered to protect the valuable compounds and keep the plants safe from harmful things.

Nutrients the plants receive are carefully managed too. As the plants grow and start to produce buds, they need different nutrients. Nitrogen is decreased, while phosphorus and potassium are increased. This helps the plants make better buds and resin.

Watering the plants is like giving them a drink. But as harvest time approaches, watering changes. This helps the plants get rid of extra nutrients and prepare for harvest. It’s important to do this carefully so the flavor and smell of the final product stay good.

As the plants get closer to harvest, growers need to be very attentive. The plants need less water, so growers have to be careful not to overwater them. Some growers use special tools to measure how much moisture is in the plants’ growing medium. This helps them make the right decisions and keep the plants healthy.

In the end, everything comes down to balance. The right amount of light, the best temperature and humidity, the nutrients, and the water — everything needs to be just right. And as the time for harvest comes, growers carefully balance all these factors to make sure the plants are healthy and ready to become the products that people enjoy. It’s a mix of science and care, creating a special connection between humans and the plants they grow.

When the cultivation conditions are just right, upstream companies such as IGC Pharma Inc. (NYSE American: IGC) can obtain top-notch cannabis compounds to use in their efforts to develop standardized medicines that meet FDA requirements.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Recreational Marijuana Legalization Law Takes Effect in Minnesota

Minnesota has recently joined the growing list of states that have legalized recreational cannabis use for adults aged 21 and older. This move marks a significant shift in the state’s approach to cannabis. Below are several key developments shaping the new landscape:

Legalization timeline

Minnesota’s journey toward cannabis legalization has been gradual. In 2014, the state took its first steps by legalizing limited medical marijuana use, which included nonsmokable forms such as oils and pills.

In 2022, edibles containing small amounts of hemp-derived THC were also legalized. This year, on May 30, 2023, Governor Tim Walz signed a comprehensive cannabis legalization bill into law, permitting recreational use for adults starting on Aug. 1.

Dispensaries and tribal sovereignty

While recreational dispensaries are not expected to open until the state establishes a licensing system and tribal governments have been granted more autonomy. Minnesota’s 11 Native American tribal nations hold sovereignty, allowing them to operate independently of state regulations.

This unique situation led to the opening of the first recreational marijuana dispensary, NativeCare, on the Red Lake Nation on Aug. 1.

Possession and cultivation

Although dispensaries are not yet fully operational, Minnesotans have the right to possess, use and even grow cannabis within certain limits. Possession of up to two ounces in public is no longer a crime, and individuals can also have edibles with up to 800 mg of THC as well as cultivate up to eight marijuana plants at home. However, exceeding this limit could result in penalties.

Taxation and regulation

Minnesota has introduced a 10% tax on retail cannabis products, with 80% of the proceeds designated to cover state regulatory costs and the remaining 20% benefiting local governments.

The newly established Office of Cannabis Management will oversee the regulation of the industry, including setting standards and managing licensing. The funds generated will also support public health initiatives, training for drug recognition evaluators and research on cannabis.

Variations and employer policies

Local municipalities have the authority to impose temporary restrictions on cannabis sales until 2025. This has led to a patchwork of regulations across different cities and towns. Similarly, employers can still prohibit cannabis use for certain safety-sensitive roles but must inform employees of their drug-testing policies.

Criminal records and expungement

Minnesota is taking steps to address the impact of previous marijuana convictions. Records related to low-level offenses are being automatically sealed, benefiting thousands of individuals. Cases involving more serious offenses will have a pathway for review and potential expungement, though those involving violence or danger are unlikely to qualify. This process aims to provide a fresh start for many who have been affected by past convictions.

Medical marijuana and future outlook

Minnesota’s medical marijuana program remains intact, serving patients with qualifying conditions. The impact of recreational legalization on medical cannabis providers is uncertain, as is the potential entry of these providers into the recreational market.

The state continues to evolve its cannabis regulations, with changes to the medical program scheduled for 2025.

Minnesota state fair policy

The Minnesota state fair, while possessing its own legal autonomy, has chosen to prohibit cannabis smoking on its grounds in 2023. Discussions about potential rule changes for future fairs remain open.

The implementation of the recreational marijuana law in the state is likely to come with a boom in the sales of many companies, including ancillary ones such as Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Intent for Human Clinical Study for Diabetes and Weight Loss Following Positive DehydraTECH(TM)-CBD Results in Animals

Lexaria’s patented DehydraTECH(TM)-CBD achieved promising results for diabetes control and weight loss in animals during the pre-clinical animal study DIAB-A22-1
The weight loss drug market was valued at $1.90 billion in 2021 and is expected to reach $13.26 billion by 2029, growing at a CAGR of 24.7%
Many drugs used to control diabetes have produced results in managing obesity, which Lexaria plans to leverage with its DehydraTECH(TM) technology

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, recently announced its intent to conduct a human clinical study to examine its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for diabetes control and weight loss. The company has already completed a pre-clinical diabetes study in animals, which supports its advancement to human trials for diabetes control and weight loss (https://cnw.fm/H1XXZ).

Lexaria had announced in two prior press releases, on March 2 and June 16, that its pre-clinical diabetes study DIAB-A22-1 in obese diabetic-conditioned animals, that DehydraTECH-CBD had achieved the following:

Lowered blood glucose levels by 19.9% (p<0.05)
Lowered overall body weight by 7% sustained over eight weeks
Witnessed a statistically significant increase in locomotor activity (p<0.05)
Lowered triglyceride levels by more than 25% (p<0.007)
Lowered blood urea nitrogen levels by 27.9% (p<0.001)

Based on these successful pre-clinical results, the management of Lexaria has decided to undertake a human diabetes clinical study to investigate whether any of these improvements will also be evidenced in humans. Lexaria is currently designing the study, which will be followed by submission to an independent review board to gain necessary approvals.

According to the Centers for Disease Control (“CDC”), managing one’s blood sugar levels is important to avoid diabetes-related conditions, including vision loss, heart disease, and kidney disease (https://cnw.fm/cgbJX). Generic CBD studies, mainly conducted in animals, indicate that it may be ineffective in controlling blood sugar. Lexaria hopes to study whether the DehydraTECH-CBD formulation provides additional insight into human blood sugar control. The company is encouraged by DehydraTECH-CBD’s ability to reduce animal blood sugar levels and believes it warrants additional investigation.

The DehydraTECH technology is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active pharmaceutical ingredients (“APIs”). DehydraTECH increases effectiveness and improves the way these APIs enter the bloodstream. The benefits of ingesting a DehydraTECH-enabled drug or consumer product include the following:

Speeds up delivery with effects of the product felt in minutes
Increases bioavailability due to its effectiveness in delivering a drug into the bloodstream
Increases brain absorption, with animal testing evidencing higher drug quantities delivered across the blood-brain barrier
Improved drug potency, with more of the drug available to the body, requiring lower dosages
Reduced drug administration costs, meaning that lower dosages require less drug cost overall
Mask unwanted tastes and reduces or eliminate the need for sweeteners

The company has also collaborated with the National Research Council (“NRC”), the Canadian government’s premier research and technology organization. DehydraTECH is covered by over 30 granted patents, with more pending worldwide. The patent protection includes formulations for specific delivery of cannabinoids, antiviral drugs, nicotine and more.

Many drugs used to control human blood glucose levels have shown promising weight loss results. The weight loss drug market was valued at $1.90 billion in 2021 and is expected to reach $13.26 billion by 2029, growing at a CAGR of 24.7% (https://cnw.fm/of7Pg). The market is growing due to the public’s growing interest in how obesity contributes to other health problems. Lexaria is positioning itself to potentially penetrate this market with its human-based clinical trial of DehydraTECH-CBD and diabetes control.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Bipartisan Senators in Pennsylvania File Bill Allowing Licensed Patients to Grow Medical Marijuana

A group of bipartisan senators in Pennsylvania have introduced a measure to expand Pennsylvania’s medical marijuana program by allowing patients aged 21 years and older to cultivate cannabis plants at home for personal use. The measure would allow registered medical marijuana patients in the state to grow up to six cannabis plants at home in a locked and enclosed location away from “ordinary public view.” Furthermore, it would grant medical cannabis dispensaries the right to sell cannabis seeds for home cultivation to registered patients.

Introduced by Senators Dan Laughlin and Sharif Street alongside half a dozen other senators, the bill does not seem to limit the total number of cannabis plants that could be cultivated in a home with more than one registered medical cannabis patient.

The measure has now been sent to the Senate Law and Justice Committee. Street and Laughlin said that since Pennsylvania legalized medical cannabis in 2016, the state’s medical cannabis program has ensured citizens across the Commonwealth can access lifesaving medicine. In a memo soliciting cosponsors for their medical cannabis home cultivation bill, the two senators wrote that while Pennsylvania’s MMJ industry has undoubtedly been beneficial, it is still inefficient in terms of access and cost.

They noted that records from the PA Department of Health show that some patients have to travel for more than two hours to access a medical cannabis dispensary, making the treatment unfeasible for a lot of Pennsylvanians. Furthermore, the senators wrote, medical cannabis patients in the state have long complained of the high costs of purchasing medical marijuana that make the treatment even more inaccessible.

The two stressed the importance of creating policies that “meet people where they are,” adding that legalizing home cultivation of medical cannabis would address the key issues of accessibility and cost that bog down Pennsylvania’s medical marijuana industry. It would also ensure that Pennsylvania residents have better means of meeting their health needs and are treated fairly and equitably under the state’s medical cannabis law.

As per the proposed measure, patients who cultivate more than the allowed number of cannabis plants or gift cannabis plants or products to other people may be liable to punishments, such as the loss of their home cultivation rights.

Laughlin and Street had introduced a recreational cannabis legalization bill last session, but it ultimately failed to advance. However, the two senators say the medical cannabis home cultivation bill is a significant improvement to the recreational cannabis bill, and they are optimistic about its chances of success.

With more people turning to medical marijuana to ease their symptoms in different jurisdictions, the marijuana-based formulations being developed by enterprises such as IGC Pharma Inc. (NYSE American: IGC) could have a large market to address, especially among those who want the medical benefits marijuana can bring minus running the associated risks, such as job losses due to positive drugs tests.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — NYC Ranks First Globally Among Cannabis-Consuming Cities

A recent study reveals that New York City stands as the global leader in marijuana consumption, surpassing all other cities with an annual intake of 62.3 metric tons, equivalent to around 137,000 pounds. Conducted under the title “2023 Global Marijuana Price Index,” this comprehensive research effort was orchestrated by the CFAH, a reputable source for health-related information. The meticulous data collection spanned 140 urban centers worldwide, analyzing marijuana pricing trends.

The CFAH team closely scrutinized nations at the extremes of marijuana consumption, a criterion that aided in narrowing down the selection of cities for the study. The legal framework for marijuana in each geographical area played a pivotal role in this selection process. Ultimately, 140 cities were singled out to present a comprehensive and insightful global marijuana pricing comparison.

The CFAH relied on WHO data and analytics to capture the overall consumption landscape. Meanwhile, the pricing trends within the United States were modeled using the SARIMA method, which effectively accounts for data trends.

In terms of marijuana consumption, NYC differs from its peers by a large margin. Despite Australia’s official prohibition of marijuana, Sydney came in second with a consumption of 45.7 metric tons per year. Los Angeles, with an annual intake of 36 metric tons, took third place. Rome and Chicago, with 24.9 and 21.8 metric tons each, came in fourth and fifth, respectively. Other cities that were included in the study and made it to the top 20 list include Toronto, Houston, Tokyo, Vienna, Prague, Phoenix, Hamburg, Montreal, Vancouver, Melbourne, Uskudar, Philadelphia, Dublin, Annapolis and Denver.

Tokyo has the highest cannabis prices, commanding a rate of $33.8 per gram. Dublin, Ireland, came in second at $22.50, while Tallinn, Estonia, followed closely with $22.10 per gram. In contrast, Montreal, Canada, boasted the most affordable marijuana, priced at a mere $5.90 per gram. Following at $6 and $6.20 per gram, respectively, were Bangalore, India, and Notre Dame, Canada.

While the prevailing assumption often links legality to increased accessibility and subsequently reduced prices, the study highlights a more nuanced reality. Both the priciest and the most budget-friendly marijuana cities maintained a delicate equilibrium between legal and illegal statuses.

Among the ten cities with the highest marijuana prices, six enforced prohibitions while the remaining four legalized marijuana. Likewise, the cities offering the least expensive marijuana displayed a minor divergence, with six embracing legality and four upholding its illegal status.

These high marijuana consumption rates create openings for entities such as Advanced Container Technologies Inc. (OTC: ACTX) to do brisk business supplying cultivation equipment to the enterprises growing this marijuana for sale on the market.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.